News from us and our partners

Tags

Topics

0 results

News
2 July, 2020
Sofinnova MD Start III announces first two medtech investments
News
30 June, 2020
Redx Pharma proposes $30M financing via convertible loan notes
News
25 June, 2020
ELSAN partners with MD Start III to accelerate medtech innovation
News
22 June, 2020
Mainstay Medical wins FDA approval for ReActiv8 in chronic low back pain
News
17 June, 2020
Shockwave Announces Pricing of Public Offering of Common Stock
News
15 June, 2020
Inventiva’s lanifibranor meets the primary and key secondary endpoints in the Phase IIb NATIVE clinical trial in non-alcoholic steatohepatitis (NASH)
News
15 June, 2020
Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board
News
12 June, 2020
Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation
News
11 June, 2020
Sofinnova Partners announces sale of Corvidia Therapeutics to Novo Nordisk
News
11 June, 2020
AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros for the industrial production of new bio-based products
News
10 June, 2020
Protera Closes $5.6M Series A Financing led by Sofinnova Partners
News
9 June, 2020
Mainstay Medical wins reimbursement approval for ReActiv8 in Australia
News
9 June, 2020
Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy
News
9 June, 2020
Biotalys expands executive team and establishes U.S. headquarters to strengthen North American presence
News
5 June, 2020
Calliditas Therapeutics Prices its Initial Public Offering on The Nasdaq Global Select Market in the United States
News
3 June, 2020
NodThera Announces Close of $55 Million Series B Financing

Sofinnova MD Start III announces first two medtech investments

Redx Pharma proposes $30M financing via convertible loan notes

ELSAN partners with MD Start III to accelerate medtech innovation

Mainstay Medical wins FDA approval for ReActiv8 in chronic low back pain

Shockwave Announces Pricing of Public Offering of Common Stock

Inventiva’s lanifibranor meets the primary and key secondary endpoints in the Phase IIb NATIVE clinical trial in non-alcoholic steatohepatitis (NASH)

Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board

Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation

Sofinnova Partners announces sale of Corvidia Therapeutics to Novo Nordisk

AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros for the industrial production of new bio-based products

Protera Closes $5.6M Series A Financing led by Sofinnova Partners

Mainstay Medical wins reimbursement approval for ReActiv8 in Australia

Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy

Biotalys expands executive team and establishes U.S. headquarters to strengthen North American presence

Calliditas Therapeutics Prices its Initial Public Offering on The Nasdaq Global Select Market in the United States

NodThera Announces Close of $55 Million Series B Financing